Results 201 to 210 of about 115,086 (341)

Meropenem‐Heparin Lock Therapy for Ochrobactrum intermedium Catheter‐Related Bloodstream Infection in a Pediatric Hemodialysis Patient: A Case Report and Literature Review

open access: yesHemodialysis International, EarlyView.
ABSTRACT Background In pediatric hemodialysis patients with exhausted vascular access, managing rare pathogens like Ochrobactrum intermedium is challenging, often posing a dilemma between catheter removal and salvage attempts. There are few reports on the supported viability of meropenem‐heparin lock therapy for this purpose in pediatric patients. Case
Mônica Cristina Dutra Rodrigues   +4 more
wiley   +1 more source

Assessing Cardiac Flow Measurements Using a Noninvasive Photoplethysmography-Based Device Compared to Invasive Pulmonary Artery Catheter. [PDF]

open access: yesJACC Adv
Nachman D   +13 more
europepmc   +1 more source

CON: Pulmonary artery catheter use should be forgone in modern clinical practice. [PDF]

open access: yesAnn Card Anaesth, 2021
Navas-Blanco JR   +3 more
europepmc   +1 more source

Variability in interventions with pulmonary artery catheter data [PDF]

open access: bronze, 2003
Manu Jain   +3 more
openalex   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

PRO: The pulmonary artery catheter has a paramount role in current clinical practice. [PDF]

open access: yesAnn Card Anaesth, 2021
Szabo C   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy